Riskpilot← Back to searchSign inGet full accessIndlægsklinikken.dk ApS
APSActiveCVR 31617375Vesterbrogade 94Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20088 employees
Revenue 2025
DKK 3,7M
+30% vs 2024
EBITDA margin
18.2%
+169% vs 2024
Equity ratio
49.8%
Financial strength
Net profit 2025
DKK 488K
+203% vs 2024
| Revenue | DKK 3,7M | +30% |
| EBITDA | DKK 682K | +169% |
| Net profit | DKK 488K | +203% |
| Total assets | DKK 1,8M | +44% |
| Equity | DKK 917K | +55% |
| Employees | 8 | — |
Legal name
Indlægsklinikken.dk ApS
CVR number
31617375
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
4. august 2008
Share capital
DKK 125.000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den
samlede direktion.
Company purpose
Selskabets formål er at drive virksomhed med fremstilling af sko samt anden hermed beslægtet virksomhed.
Address
Vesterbrogade 94
Phone
+4527828326
Email
kontakt@i-klinikken.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 614 | 748 | 662 | 578 | 716 | 698 | 930 | 1.619 | 1.726 | 1.883 | 2.689 | 2.333 | 2.868 | 3.736 |
| Staff expenses | -477 | -474 | -605 | -645 | -602 | -603 | -724 | -1.222 | -1.265 | -1.388 | -2.031 | -2.001 | -2.614 | -3.054 |
| EBITDA | 137 | 274 | 57 | -67 | 10 | 95 | 119 | 353 | 403 | 496 | 658 | 332 | 253 | 682 |
| Depreciation & amort. | -39 | -38 | -50 | -117 | -4 | -1 | -1 | -45 | -115 | -84 | -98 | -95 | -48 | -56 |
| EBIT | 99 | 236 | 7 | -184 | 6 | 95 | 117 | 308 | 288 | 412 | 560 | 237 | 205 | 625 |
| Net financials | -3 | -3 | -1 | -9 | -5 | -2 | -5 | -3 | -7 | -4 | -2 | -3 | -0 | 1 |
| Profit before tax | 95 | 233 | 6 | -193 | 1 | 93 | 113 | 305 | 281 | 408 | 557 | 234 | 205 | 627 |
| Tax | 24 | 56 | 10 | -18 | -23 | 20 | 21 | 69 | 66 | 88 | 123 | 49 | 44 | 139 |
| Net profit | 71 | 177 | -4 | -175 | 24 | 73 | 92 | 236 | 215 | 320 | 435 | 184 | 161 | 488 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 550 | 631 | 577 | 853 | 362 | 439 | 700 | 930 | 1.186 | 1.238 | 1.631 | 1.585 | 1.278 | 1.841 |
| Equity | 232 | 361 | 260 | 86 | 110 | 182 | 337 | 464 | 428 | 549 | 863 | 614 | 591 | 917 |
| Long-term debt | 7 | 59 | 7 | 469 | 15 | 21 | 0 | 0 | 66 | 84 | 117 | 45 | 22 | 119 |
| Short-term debt | 291 | 195 | 291 | 298 | 252 | 256 | 363 | 463 | 685 | 599 | 650 | 927 | 666 | 806 |
| Total debt | 298 | 254 | 298 | 767 | 252 | 256 | 363 | 463 | 751 | 683 | 767 | 971 | 688 | 924 |
EBITDA margin
18.2%
This company
15.8%
Market median
+15% vs market
20122025
Equity ratio
49.8%
This company
38.2%
Market median
+30% vs market
20122025
Return on equity
53.2%
This company
18.4%
Market median
+189% vs market
20122025
Net profit margin
13.1%
This company
8.1%
Market median
+62% vs market
20122025
Asset turnover
2.03×
This company
1.12×
Market median
+81% vs market
20122025
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FS Management | Management | 2008 | — | — |
DD Management | Management | 2018 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Doose Holding ApS | Company | 50.0% | 50.0% | 2018 |
Pro-Sko Invest ApS | Company | 50.0% | 50.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Doose Holding ApS
Indlægsklinikken.dk ApS Board members of Indlægsklinikken.dk ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Flemming Søgaard Sørensen | Management | 0 companies |
| David Doose Schmidt | Management | 0 companies |